透明颤菌血红蛋白的表达及其对基因工程菌的影响

利用已克隆的透明颤菌血红蛋白基因,构建了一批复制类型和抗生标记不同的ｖｇｂ表达载体,并就ｖｇｂ基因表达及其对几种基因工程大肠杆菌的影响进行了初步研究。实验证明ｖｇｂ基因的表达具有氧调控特性,在溶氧水平下跌至２０％饱和度时迅速合成。ｖｇｂ基因的表达产物可促进青霉素酰化酶和ＴＮＦ、ＩＬ－２等基因工程菌在低氧条件下细胞生长和产物表达的状况,由于ｖｇｂ基因的表达降低了细胞对氧的敏感程度,可望运用它来改善发     

透明颤菌血红蛋白在发酵工业中的应用概述

透明颤菌血红蛋白在发酵工业中的应用概述郭宏秋,杨胜利（中国科学院上海生物工程研究中心,上海２００２３３）在生物技术日益产业化的今天,特别是随着基因工程技术的飞速发展,为生产新的生物产品带来了可能,有些产品已进人商业化生产,像干扰素、白细胞介素、生长激...     

脯氨酰内肽酶培养条件的优化及高密度发酵

基因工程菌E.coliBL21/pGEMPEP可以组成型表达重组的点状产气单胞菌脯氨酰内肽酶(PEP),但培养条件极大地影响着酶的产量,为了获得高效表达,首先测定了工程菌表达PEP的稳定性并考察了培养温度、pH、发酵时间、碳源、氮源、无机盐等对产酶的影响,得到了优化的发酵条件,L9(3⁴)正交试验进一步明确了摇床转速、培养温度、pH值、培养时间对产酶量的影响都有高度的统计学意义。在此基础上利用NBSBioFlo3000型5L自控发酵罐进行了高密度、高表达发酵、经20h培养,最终菌体密度达OD₆₀₀60(相当于干菌体225g/L),PEP表达量为28%,每升发酵液中含PEP酶315g。     

基因工程菌的发酵研究

本文对大肠杆菌表达的ｒｈＧＭ－ＣＳＦ工程菌的发酵条件进行了详细的研究,探讨了发酵条件对工程菌表达外源蛋白量的影响,优化了影响发酵的各种条件,形成了一套工程菌发酵表达外源蛋白的工艺,并从工业化角度对工程菌的高密度高表达间的关系进行了探讨。     

基因工程菌生产重组人组织因子的发酵研究

根据表达重组人组织因子基因工程菌的自身特点,在30L发酵罐上,通过控制发酵pH、葡萄糖浓度、诱导物磷酸浓度、搅拌速度及采用分批补料等方法,对重组人组织因子基因工程菌高密度发酵和高效表达的条件进行了研究。实验结果表明:诱导物终浓度低于0.1mmol/L,菌体密度OD60014,发酵周期10.5h,基因工程菌批发酵平均产量为37.41g/L,重组人组织因子表达量为6.56 mg/L。关键词:基因工程菌;高密度发酵;组织因子     

基因工程菌高密度发酵工艺研究进展

阐述了基因工程菌高密度发酵工艺的几个主要影响因素,包括重组菌构建、培养条件、生长抑制因子以及它们的控制技术。通过高密度发酵可以提高细胞生长密度、目的蛋白的表达含量。在高密度发酵过程中,会产生一些有害抑制代谢副产物,但通过分批补料可以降低影响。     

基因工程菌发酵生产L-乳酸研究进展

乳酸是重要的工业平台化学品。随着聚乳酸产业的兴起,对高质量L-乳酸的需求量也不断增加。为了进一步降低L-乳酸发酵成本,提高菌株的工业适应性,各种现代生物技术已经应用到L-乳酸发酵菌种的改造上来。文中简要综述了近年来使用乳酸菌、酵母、大肠杆菌及米根霉等基因工程菌株发酵生产L-乳酸的技术进展。     

Effects of mutations in acetate metabolism on high-cell-density growth of Escherichia coli

To study the role played by acetate metabolism during high-cell-density growth of Escherichia coli cells, we constructed isogenic null mutants of strain W3100 deficient for several genes involved either in acetate metabolism or the transition to stationary phase. We grew these strains under identical fed-batch conditions to the highest cell densities achievable in 8 h using a predictive-plus-feedback-controlled computer algorithm that maintained glucose at a set-point of 0.5 g/l, as previously described. Wild-type strains, as well as mutants lacking the s^s subunit of RNA polymerase (rpoS), grew reproducibly to high cell densities (44–50 g/l dry cell weights, DCWs). In contrast, a strain lacking acetate kinase (ackA) failed to reach densities greater than 8 g/l. Strains lacking other acetate metabolism genes (pta, acs, poxB, iclR, and fadR) achieved only medium cell densities (15–21 g/l DCWs). Complementation of either the acs or the ackA mutant restored wild-type high-cell-density growth. On a dry weight basis, poxB and fadR strains produced approximately threefold more acetate than did the wild-type strain. In contrast, the pta, acs, or rpoS strains produced significantly less acetate per cell dry weight than did the wild-type strain. Our results show that acetate metabolism plays a critical role during growth of E. coli cultures to high cell densities. They also demonstrate that cells do not require the s^s regulon to grow to high cell densities, at least not under the conditions tested. Journal of Industrial Microbiology & Biotechnology (2000) 24, 421–430. Received 12 November 1999/ Accepted in revised form 24 February 2000     

Characterization and feasibility of a miniaturized stirred tank bioreactor to perform E. coli high cell density fed-batch fermentations

The use of small scale bioreactors that are mechanically and functionally similar to large scale reactors is highly desirable to accelerate bioprocess development because they enable well-defined scale translations. In this study, a 25-mL miniaturized stirred tank bioreactor (MSBR) has been characterized in terms of its power input, hydrodynamics, and volumetric oxygen transfer coefficient (k(L)a) to assess its potential to grow high cell density (HCD) cultures using adequate scale-down criteria. Engineering characterization results show scale down, based on matched specific power input (P(G)/V), is feasible from a 20-L pilot scale stirred tank bioreactor. Results from fed-batch fermentations performed using Fab' producing E. coli W3110 at matched (P(G)/V) in the MSBR and 20-L STR demonstrated that the MSBR can accurately scale down the 20-L fermentation performance in terms of growth and Fab' production. Successful implementation of a fed-batch strategy in the MSBR resulted in maximum optical density of ca. 114 and total Fab' concentration of 940 μg/mL compared with ca. 118 and 990 μg/mL in 20-L STR. Furthermore, the use of the MSBR in conjunction with primary recovery scale-down tools to assess the harvest material of both reactors showed comparable shear sensitivity and centrifugation performance. The conjoint use of the MSBR with ultra scale-down (USD) centrifugation mimics can provide a cost-efficient manner in which to design and develop bioprocesses that account for good upstream performance as well as their manufacturability downstream.     

Investigation of the impact of Tat export pathway enhancement on E. coli culture, protein production and early stage recovery

The twin arginine translocation (Tat) pathway occurs naturally in E. coli and has the distinct ability to translocate folded proteins across the inner membrane of the cell. It has the potential to export commercially useful proteins that cannot be exported by the ubiquitous Sec pathway. To better understand the bioprocess potential of the Tat pathway, this article addresses the fermentation and downstream processing performances of E. coli strains with a wild‐type Tat system exporting the over‐expressed substrate protein FhuD. These were compared to strains cell‐engineered to over‐express the Tat pathway, since the native export capacity of the Tat pathway is low. This low capacity makes the pathway susceptible to saturation by over‐expressed substrate proteins, and can result in compromised cell integrity. However, there is concern in the literature that over‐expression of membrane proteins, like those of the Tat pathway, can impact negatively upon membrane integrity itself. Under controlled fermentation conditions E. coli cells with a wild‐type Tat pathway showed poor protein accumulation, reaching a periplasmic maximum of only 0.5 mg L^?1 of growth medium. Cells over‐expressing the Tat pathway showed a 25% improvement in growth rate, avoided pathway saturation, and showed 40‐fold higher periplasmic accumulation of FhuD. Moreover, this was achieved whilst conserving the integrity of cells for downstream processing: experimentation comparing the robustness of cells to increasing levels of shear showed no detrimental effect from pathway over‐expression. Further experimentation on spheroplasts generated by the lysozyme/osmotic shock method—a scaleable way to release periplasmic protein—showed similar robustness between strains. A scale‐down mimic of continuous disk‐stack centrifugation predicted clarifications in excess of 90% for both intact cells and spheroplasts. Cells over‐expressing the Tat pathway performed comparably to cells with the wild‐type system. Overall, engineering E. coli cells to over‐express the Tat pathway allowed for greater periplasmic yields of FhuD at the fermentation scale without compromising downstream processing performance. Biotechnol. Bioeng. 2012; 109:983–991. © 2011 Wiley Periodicals, Inc.     

Temperature gradient-based high-cell density fed-batch fermentation for the production of pyruvate oxidase by recombinant E. coli

Pyruvate oxidase (PyOD) is a very powerful enzyme for clinical diagnostic applications and environmental monitoring. Influences of temperature on cell growth, plasmid stability, and PyOD expression during the PyOD fermentation process by recombinant Escherichia coli were investigated. Based on the influences of temperature on the physiological metabolism, a novel high-cell density fed-batch cultivation with gradient temperature decrease strategy for effective PyOD production was achieved, under which the biomass (OD₆₀₀) of recombinant E. coli could reach to 71 and the highest PyOD activity in broth could reach to 3,307 U/L in 26?hr fermentation.     

低免疫原性的新型葡激酶ΔNMSak在大肠杆菌中的高效表达和分离纯化

为了降低野生型葡激酶 (wild- type staphylokinase,wt- Sak)的免疫原性 ,对已构建的葡激酶N端缺失突变体 (ΔNSak) c DNA进行改造 ,将其主要的抗原决定簇编码序列突变为丙氨酸密码子 .该突变体 (ΔNMSak) c DNA与原核表达载体 p LY- 4重组后 ,转化大肠杆菌 JF1 1 2 5.经温度诱导 ,ΔNMSak获得高效表达 ,重组蛋白占全菌总蛋白的 60 % ,以包涵体形式存在 .包涵体经洗涤 ,8mol/L尿素溶解 ,稀释复性 ,离子交换色谱一步分离至电泳纯 ,纯度达 95%以上 ,分子量与理论值相符 ,比活性 8.5× 1 0 4 HU/mg.经 ELISA法、发色底物法测定 ,ΔNMSak与 wt- Sak制备的兔抗wt- Sak抗血清的免疫反应性显著降低 ,经抗血清温育后 ,wt- Sak活性下降程度远高于 ΔNMSak.ΔNMSak、wt- Sak分别免疫豚鼠 ,以 ELISA法测定豚鼠血清中相应抗体的效价 ,ΔNMSak组的抗体效价明显低于 wt- Sak组 ,表明 ΔNMSak的免疫原性显著下降 .     

Utility of an Escherichia coli strain engineered in the substrate uptake system for improved culture performance at high glucose and cell concentrations: an alternative to fed-batch cultures

Overflow metabolism is an undesirable characteristic of aerobic cultures of Escherichia coli. It results from elevated glucose consumption rates that cause a high substrate conversion to acetate, severely affecting cell physiology and bioprocess performance. Such phenomenon typically occurs in batch cultures under high glucose concentration. Fed-batch culture, where glucose uptake rate is controlled by external addition of glucose, is the classical bioprocessing alternative to prevent overflow metabolism. Despite its wide-spread use, fed-batch mode presents drawbacks that could be overcome by simpler batch cultures at high initial glucose concentration, only if overflow metabolism is effectively prevented. In this study, an E. coli strain (VH32) lacking the phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) with a modified glucose transport system was cultured at glucose concentrations of up to 100 g/L in batch mode, while expressing the recombinant green fluorescence protein (GFP). At the highest glucose concentration tested, acetate accumulated to a maximum of 13.6 g/L for the parental strain (W3110), whereas a maximum concentration of only 2 g/L was observed for VH32. Consequently, high cell and GFP concentrations of 52 and 8.2 g/L, respectively, were achieved in VH32 cultures at 100 g/L of glucose. In contrast, maximum biomass and GFP in W3110 cultures only reached 65 and 48%, respectively, of the values attained by the engineered strain. A comparison of this culture strategy against traditional fed-batch culture of W3110 is presented. This study shows that high cell and recombinant protein concentrations are attainable in simple batch cultures by circumventing overflow metabolism through metabolic engineering. This represents a novel and valuable alternative to classical bioprocessing approaches.     

低免疫原性的新型葡激酶ΔNMSak在大肠杆菌中的高效表达和分离纯化

为了降低野生型葡激酶 (wild- type staphylokinase,wt- Sak)的免疫原性 ,对已构建的葡激酶N端缺失突变体 (ΔNSak) c DNA进行改造 ,将其主要的抗原决定簇编码序列突变为丙氨酸密码子 .该突变体 (ΔNMSak) c DNA与原核表达载体 p LY- 4重组后 ,转化大肠杆菌 JF1 1 2 5.经温度诱导 ,ΔNMSak获得高效表达 ,重组蛋白占全菌总蛋白的 60 % ,以包涵体形式存在 .包涵体经洗涤 ,8mol/L尿素溶解 ,稀释复性 ,离子交换色谱一步分离至电泳纯 ,纯度达 95%以上 ,分子量与理论值相符 ,比活性 8.5× 1 0 4 HU/mg.经 ELISA法、发色底物法测定 ,ΔNMSak与 wt- Sak制备的兔抗wt- Sak抗血清的免疫反应性显著降低 ,经抗血清温育后 ,wt- Sak活性下降程度远高于 ΔNMSak.ΔNMSak、wt- Sak分别免疫豚鼠 ,以 ELISA法测定豚鼠血清中相应抗体的效价 ,ΔNMSak组的抗体效价明显低于 wt- Sak组 ,表明 ΔNMSak的免疫原性显著下降 .     

Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation

VB4-845 is a recombinant immunotoxin comprised of an anti-epithelial cell adhesion molecule (EpCAM) scFv fused to a truncated form of the bacterial toxin, Pseudomonas exotoxin A. VB4-845, purified from TB fed-batch fermentation, showed clinical efficacy when administered locally to treat non-muscle invasive bladder cancer (NMIBC) and squamous cell carcinomas of the head and neck (SCCHN). Here, we describe the implementation of an Escherichia coli high cell density (HCD) cultivation and purification process for VB4-845. HCD cultivation was a prerequisite for achieving higher yields necessary for Phase III clinical trials and commercialization. Using this process, the VB4-845 titer in the supernatant was increased by 30-fold over the original TB fed-batch cultivation. To obtain clinical grade material, a process involving a five-step column purification procedure was implemented and led to an overall recovery of ～ 40%. VB4-845 purity of >97% was achieved after the first three columns following the removal of low-molecular weight product-related impurities and aggregates. Endotoxins were effectively separated from VB4-845 on the Q-columns and by washing the Ni-column with a detergent buffer while host cell proteins were removed using ceramic hydroxyapatite. Comparability studies demonstrated that the purified product from the Phase III process was identical to the Phase II reference standard produced using TB fed-batch fermentation.     

一种新的丙型肝炎病毒单链丝氨酸蛋白酶基因的构建、表达与鉴定

根据丙型肝炎病毒 (HCV)丝氨酸蛋白酶晶体结构特点 ,设计并构建了一种新的单链型丝氨酸蛋白酶分子 .该分子由辅因子NS4A的核心序列、柔性连接子GSGS和NS3丝氨酸蛋白酶结构域组成 .利用设计的 3条引物 ,通过 2轮PCR获得单链丝氨酸蛋白酶基因 ,插入原核表达载体pQE30中 ,转化大肠杆菌M15 ,获得重组克隆 .经低剂量诱导和低温培养 ,目的基因获得高水平可溶表达 .以金属螯合层析法纯化的重组蛋白纯度达 95 %以上 .间接ELISA法检测 98份血清证实 ,该蛋白具有良好的抗原性和特异性 ;以重组蛋白底物NS5ab和单链丝氨酸蛋白酶建立了简便、实用的丝氨酸蛋白酶体外活性检测系统 ;以该系统观察了PMSF和EDTA对蛋白酶活性的影响 .结果表明 ,PMSF能够抑制蛋白酶的酶切活性 ,而EDTA不能抑制酶的活性 .单链型HCV丝氨酸蛋白酶的成功表达以及体外活性检测系统的建立 ,为丝氨酸蛋白酶抑制剂的研制奠定了物质基础 .     

Isolation of a solventogenic Clostridium sp. strain: Fermentation of glycerol to n-butanol,analysis of the bcs operon region and its potential regulatory elements

A new solventogenic bacterium, strain GT6, was isolated from standing water sediment. 16S-rRNA gene analysis revealed that GT6 belongs to the heterogeneous Clostridium tetanomorphum group of bacteria exhibiting 99% sequence identity with C. tetanomorphum 4474^T. GT6 can utilize a wide range of carbohydrate substrates including glucose, fructose, maltose, xylose and glycerol to produce mainly n-butanol without any acetone. Additional products of GT6 metabolism were ethanol, butyric acid, acetic acid, and trace amounts of 1,3-propanediol. Medium and substrate composition, and culture conditions such as pH and temperature influenced product formation. The major fermentation product from glycerol was n-butanol with a final concentration of up to 11.5 g/L. 3% (v/v) glycerol lead to a total solvent concentration of 14 g/L within 72 h. Growth was not inhibited by glycerol concentrations as high as 15% (v/v).